GTG shares soar on back of Applera lawsuit news
Monday, 20 September, 2004
The share price of Genetic Technologies (ASX: GTG) has risen over 50 per cent since the judge in GTG's lawsuit against Applera ruled largely in the company's favour during the Markman hearing last Thursday.
GTG were up from AUD$0.38 last Thursday to AUD$0.59 at time of writing.
In the hearing, the court examined 15 disputed technical terms within GTG's patent claims, ruling in favour of GTG's definition in 13 cases, and adopting a definition consistent with GTG's position for the other two terms.
Neurosensing/neurostimulation implants session to be held on Monday
On Monday, a session at UNSW Sydney will include people who are benefiting from bioelectronics...
argenx and Monash University partner against autoimmune diseases
To advance a pioneering molecule for autoimmune diseases, global immunology company argenx has...
Archer completes potassium sensing alpha prototype
Quantum technology company Archer Materials Limited has developed an early Biochip prototype...
